dc.creatorBertoldo, Jean Borges
dc.creatorChiaradia Delatorre, Louise Domeneghini
dc.creatorMascarello, Alessandra
dc.creatorLeal, Paulo César
dc.creatorSechini Cordeiro, Marlon Norberto
dc.creatorNunes, Ricardo José
dc.creatorSalas Sarduy, Emir
dc.creatorRosenthal, Philip Jon
dc.creatorTerenzi, Hernán
dc.date.accessioned2020-01-23T15:43:46Z
dc.date.accessioned2022-10-14T23:07:33Z
dc.date.available2020-01-23T15:43:46Z
dc.date.available2022-10-14T23:07:33Z
dc.date.created2020-01-23T15:43:46Z
dc.date.issued2015-02
dc.identifierBertoldo, Jean Borges; Chiaradia Delatorre, Louise Domeneghini; Mascarello, Alessandra; Leal, Paulo César; Sechini Cordeiro, Marlon Norberto; et al.; Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum; Taylor & Francis Ltd; Journal of Enzyme Inhibition and Medicinal Chemistry; 30; 2; 2-2015; 299-307
dc.identifier1475-6366
dc.identifierhttp://hdl.handle.net/11336/95659
dc.identifier1475-6374
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4317543
dc.description.abstractFalcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many previous studies have identified FP-2 inhibitors; however, none has yet met the criteria for an antimalarial drug candidate. In this work, we assayed an in-house library of non-peptidic organic compounds, including (E)-chalcones, (E)-N'-benzylidene-benzohydrazides and alkyl-esters of gallic acid, and assessed the activity toward FP-2 and their mechanisms of inhibition. The (E)-chalcones 48, 54 and 66 showed the lowest IC50 values (8.5±0.8μM, 9.5±0.2μM and 4.9±1.3μM, respectively). The best inhibitor (compound 66) demonstrated non-competitive inhibition, and using mass spectrometry and fluorescence spectroscopy assays, we suggest a potential allosteric site for the interaction of this compound, located between the catalytic site and the hemoglobin binding arm in FP-2. We combined structural biology tools and mass spectrometry to characterize the inhibition mechanisms of novel compounds targeting FP-2.
dc.languageeng
dc.publisherTaylor & Francis Ltd
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.3109/14756366.2014.920839
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3109/14756366.2014.920839
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFALCIPAIN 2
dc.subjectPLASMODIUM
dc.subjectMALARIA
dc.subjectCHALCONES
dc.titleSynthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución